Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Cullinan Therapeutics Inc has a consensus price target of $29.14 based on the ratings of 9 analysts. The high is $40 issued by Stifel on May 1, 2024. The low is $19 issued by Morgan Stanley on February 3, 2023. The 3 most-recent analyst ratings were released by Wedbush, HC Wainwright & Co., and HC Wainwright & Co. on August 9, 2024, June 3, 2024, and May 24, 2024, respectively. With an average price target of $30.67 between Wedbush, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 56.46% upside for Cullinan Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Cullinan Therapeutics (NASDAQ:CGEM) was reported by Wedbush on August 9, 2024. The analyst firm set a price target for $36.00 expecting CGEM to rise to within 12 months (a possible 83.67% upside). 13 analyst firms have reported ratings in the last year.
The latest analyst rating for Cullinan Therapeutics (NASDAQ:CGEM) was provided by Wedbush, and Cullinan Therapeutics reiterated their outperform rating.
There is no last upgrade for Cullinan Therapeutics
There is no last downgrade for Cullinan Therapeutics.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cullinan Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cullinan Therapeutics was filed on August 9, 2024 so you should expect the next rating to be made available sometime around August 9, 2025.
While ratings are subjective and will change, the latest Cullinan Therapeutics (CGEM) rating was a reiterated with a price target of $36.00 to $36.00. The current price Cullinan Therapeutics (CGEM) is trading at is $19.60, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.